TCI Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-38
| Closed | -$7.61K | – | 284 |
|
|
2023
Q1 | $7.61K | Buy |
38
+9
| +31% | +$1.89K | ﹤0.01% | 1247 |
|
|
2022
Q4 | $6.89K | Buy |
29
+25
| +625% | +$5.33K | ﹤0.01% | 1321 |
|
|
2022
Q3 | $1K | Buy |
4
+1
| +33% | +$191 | ﹤0.01% | 2022 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 2257 |
|
|
2022
Q1 | $0 | Sell |
3
-1
| -25% | -$152 | ﹤0.01% | 2207 |
|
|
2021
Q4 | $1K | Sell |
4
-35
| -90% | -$6.5K | ﹤0.01% | 2150 |
|
|
2021
Q3 | $7K | Buy |
39
+36
| +1,200% | +$6.75K | ﹤0.01% | 1327 |
|
|
2021
Q2 | $1K | Sell |
3
-21
| -88% | -$3.08K | ﹤0.01% | 2170 |
|
|
2021
Q1 | $3K | Buy |
24
+19
| +380% | +$2.86K | ﹤0.01% | 1478 |
|
|
2020
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 1321 |
|
|
2020
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 1249 |
|
|
2020
Q2 | $1K | Sell |
5
-10
| -67% | -$1.35K | ﹤0.01% | 1192 |
|
|
2020
Q1 | $2K | Buy |
15
+5
| +50% | +$577 | ﹤0.01% | 968 |
|
|
2019
Q4 | $1K | Sell |
10
-1
| -9% | -$100 | ﹤0.01% | 1271 |
|
|
2019
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 1212 |
|
|
2019
Q2 | $1K | Sell |
11
-8
| -42% | -$614 | ﹤0.01% | 1128 |
|
|
2019
Q1 | $2K | Buy |
19
+8
| +73% | +$669 | ﹤0.01% | 988 |
|
|
2018
Q4 | $1K | Sell |
11
-7
| -39% | -$538 | ﹤0.01% | 1131 |
|
|
2018
Q3 | $2K | Buy |
18
+7
| +64% | +$704 | ﹤0.01% | 991 |
|
|
2018
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 1228 |
|
|
2018
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 1075 |
|
|
2017
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 1126 |
|
|
2017
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 1053 |
|
|
2017
Q2 | $1K | Buy |
+11
| New | +$703 | ﹤0.01% | 1081 |
|
|
2017
Q1 | – | Sell |
-9
| Closed | – | – | 1279 |
|
|
2016
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 1346 |
|
|
2016
Q3 | $1K | Buy |
+9
| New | +$635 | ﹤0.01% | 1066 |
|
Other funds holding ALNY
